• Iovance approved inducement stock options covering 3,400 shares for one new, non-executive employee.
• The options were granted under the Amended and Restated 2021 Inducement Plan.
• The exercise price was USD 3.87 per share.
• Vesting is scheduled over three years, with one-third vesting on the first anniversary of the employee’s start date.
• The remaining shares vest in eight quarterly installments over the next two years, subject to continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iovance Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603201715PRIMZONEFULLFEED9675964) on March 20, 2026, and is solely responsible for the information contained therein.